Antibodies, Complement, and Anti-Tumour Immunity
Time: 8:30 am
day: Conference Day Two
Details:
- Increasing evidence implicates compliment activities in oncology
- Targeting complement factor H
- Conceptualizing drug development targeting angiogenesis in oncology
